Nath Bio-Genes Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
2023
EBITDA0
EBIT0
Earning Per Share18
Expenses253
Net Profit35
Net Profit Margin12
Operating Profit Margin16
Profit Before Tax36
Dividends Per Share0
Operation Revenue302

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202234.2638.4923119.5323
NANANANANANA
20230035.01NA36.16
2022222.87243.81212.701,269.10222.70
2021-2.49-2.47-3.2097.17-3.20
The EBITDA of Nath Bio-Genes is 0 as of 12/1/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20122023
Operating Activities038
Investing Activities0-3
Financing Activities0-2
Others00
Net Cash Flow034

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
202331.26-27.37-5.41-1.52
20034.19-11.514.65-2.67
202338.37-2.88-1.6733.81
2023296.55-118.85-176.231.47
2021-9.25-5.7715.01-0.01
The cash flow from Operating Activities of Nath Bio-Genes is 38 as of 12/1/2023